Abstract
Bhan et al1 discovered low rates of testing and treatment for mineral and bone disorders in patients with chronic kidney disease (CKD) in the primary care setting. In this study, bisphosphonates were prescribed more frequently than vitamin D as treatment for CKD mineral and bone disorders. Bhan's study1 concluded that a lack of knowledge exists about the treatment of metabolic mineral and bone disorders related to chronic kidney failure. The purpose of this article is to increase awareness about the appropriate treatment of metabolic mineral and bone disorders related to CKD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
